Health
Insilico Medicine AI COVID tool uses Xeons – Fudzilla
Intel helps in COVID-19 research Industry veteran Alex Zhavoronkov who left the PC industry (ATI and AMD) to start the AI longevity focused Insilico Medicine, has announced AI-powered COVIDomic to power the COVID-19 basic and clinical research.
Insilico Medicine is a global leader in artificial intelligence for drug discovery and development, and the company is among the first in the world to embrace the AI technologies in tools in drug discoveries. Now the company realized that it could use AI on Intel Xeon architecture to launch a new system for COVID-19 basic and clinical research.
Insilico Medicine came up with COVIDomic, a foundational technology that enables scientists to use anonymized patient data to integrate with a variety o…
-
General24 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
Noosa News9 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News23 hours agoPolice charge second man over alleged assault in Gold Coast car seller on Facebook’s Marketplace
-
General19 hours agoSharp rise in airfares push UK inflation higher in July